Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data

Infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB), especially when carbapenem resistant, have been very difficult to manage in the last fifteen years, owing to the paucity of dependable therapeutic options. Cefiderocol is a siderophore cephalosporin recently approved by the Food...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacobbe, Daniele Roberto, Ciacco, Eugenio, Girmenia, Corrado, Pea, Federico, Rossolini, Gian Maria, Sotgiu, Giovanni, Tascini, Carlo, Tumbarello, Mario, Viale, Pierluigi, Bassetti, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778378/
https://www.ncbi.nlm.nih.gov/pubmed/33402840
http://dx.doi.org/10.2147/IDR.S205309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778378/
https://www.ncbi.nlm.nih.gov/pubmed/33402840
http://dx.doi.org/10.2147/IDR.S205309

Ejemplares similares